How Agentic Commercial connects AI with biopharma teams

Biopharma companies are using Agentic Commercial to connect artificial intelligence with field teams, digital channels and approved content. The approach aims to make engagement with healthcare professionals (HCPs), patients and health systems more coordinated as therapies grow more specialized and access to HCPs becomes more limited.

In traditional commercial models, sales, medical and marketing teams often work separately. The article says that can leave HCPs with fragmented experiences and make it harder to capture why a physician made a decision or what is blocking access to treatment. Agentic call reporting uses voice and free-text tools, alongside compliance checks, to capture richer details from conversations. Early implementations show that 65% of Agentic Call Reports identify actionable treatment barriers, according to the article.

Conversational AI can also answer questions on company websites and by email using only medical, legal and regulatory (MLR)-approved content. The resulting interactions may help teams see what users ask and where information is missing, rather than only what they click.

Content review is another proposed use. The article says global pharma content expenditure has reached $30 billion annually, while 29% more assets are created year over year. Agentic MLR tools can review documents against approved labels, claim libraries and brand procedures. Content leaders anticipate that 38% of the MLR process will be AI-driven by 2028.

These claims appear in a TechRadar Pro Perspectives article by Chris Moore. It presents Agentic Commercial as a way to coordinate field, digital and content work, while noting the model relies on shared processes, governance and compliance requirements.